Silencing of IFIT3 significantly down-regulated the expression levels of IL-17 and IL-1β and inhibited the migration and invasiveness of HCC cells/Cells with low UBE2O expression and high IFIT3 expression were highly sensitive to interferon α treatment. This evidence concerns the gene IFIT3 and hepatocellular carcinoma.